Laminitis Research Gets a Boost

Pfizer Animal Health and the NTRA have joined forces to help fund laminitis research.

From Equine Resources International

Pfizer Animal Health and the National Thoroughbred Racing Association have joined forces to help fund laminitis research through the NTRA Charities - Barbaro Memorial Fund.

Owners, trainers, and horse enthusiasts can contribute directly to the work of the Barbaro Memorial Fund online at Information on the donation site will be featured in Pfizer Animal Health advertising for several equine products, as well as on displays in select retail outlets and at major equine events. "Riding with Barbaro" awareness bracelets will be available as part of select display promotions.

“Laminitis is a potentially devastating disease that affects horses at all levels of equine sports and across disciplines--from great Thoroughbred champions like Barbaro, right on to recreational horses loved by their riders and owners,” said Kristin Ruff, marketing manager of U.S. equine business at Pfizer Animal Health. “We wanted to help raise awareness of the Fund’s mission and encourage all kinds of horse people to donate what they can toward finding a cure.”

“Pfizer’s generous contribution and commitment to promote the NTRA Charities - Barbaro Memorial Fund will help further his legacy, both as a courageous and gifted racehorse, and as the inspiration for promising new research on equine health,” said Alex Waldrop, president and chief executive officer of the NTRA.

“Gretchen and I hope Barbaro’s memory can be carried on through advances in medical research, including a cure for laminitis,” said Roy Jackson, who owned Barbaro with his wife, Gretchen.